What is it about?
We have reported the discordance in immunoexpression of HER2 in primary breast carcinoma and synchronous axillary lymph node metastases.
Featured Image
Why is it important?
The positivity in lymph node metastases may allow the possibility of target therapy.
Perspectives
Improve overall survival in breast cancer patients
Dr Rosario Caltabiano
Department G.F. Ingrassia Section of Anatomic Pathology University of Catania
Read the Original
This page is a summary of: Discordance rate of HER2 status in primary breast carcinomas versus synchronous axillary lymph node metastases: a multicenter retrospective investigation, OncoTargets and Therapy, July 2014, Taylor & Francis,
DOI: 10.2147/ott.s65294.
You can read the full text:
Contributors
The following have contributed to this page
